QK CardioCare Thrombolytic Product is not a real drug, patients should be under the guidance of a professional physician for standardized treatment. QK Cardiovascular Thrombolytic Product does not have a national drug approval number and belongs to a kind of traditional Chinese medicine health food. The drug does not have any role in the treatment of thrombotic diseases of the cardiovascular system, so for patients with thrombotic diseases of the cardiovascular system to take QK cardiovascular thrombolytic is not scientific. Thrombotic diseases of the cardiovascular system such as myocardial infarction, untimely treatment can endanger the patient’s life, once the occurrence of the need for immediate medical treatment, the use of drugs thrombolytic or interventional thrombolytic treatment, if necessary, need to carry out coronary stenting surgery, can improve the patient’s prognosis, to save lives. When patients with cardiovascular disease, can not blindly believe that the so-called thrombolytic products on the market, should be timely under the guidance of a professional physician to use regular medication in order to treat the disease, improve the prognosis, to avoid delays in the condition leading to adverse consequences.